-
放疗是恶性肿瘤的3大治疗手段之一,但肿瘤细胞的放疗抵抗是导致肿瘤患者放疗失败和预后不良的重要因素[1]。环状RNA(circular RNA,circRNA)是一类新型的内源性共价闭合环状非编码RNA,无5'末端帽结构及3'末端多聚A尾[2]。circRNA的数量丰富,具有较高的细胞和组织特异性。circRNA独特的结构使其对核糖核酸酶不敏感,能够完整且高度稳定地存在于各种组织和体液中。这些特性使circRNA成为肿瘤诊断、治疗和判断预后的理想非侵入性生物标志物[3]。近年来,由于高通量测序和生物信息学技术的飞速发展,circRNA成为了继微小RNA(microRNA,miRNA)及长链非编码RNA后RNA家族在肿瘤放疗领域又一新的研究热点。研究表明,一些circRNA可调控miRNA 的功能并作为miRNA的海绵,在肿瘤的基因转录调控中发挥重要作用[4]。我们对circRNA作为新型的肿瘤标志物及其在肿瘤放疗中应用的研究进展作一综述。
环状RNA作为肿瘤标志物及其在肿瘤放疗中应用的研究进展
Progress in the research on circRNAs as tumor markers and their applications in radiotherapy
-
摘要: 放疗是肿瘤综合治疗的重要手段之一,但放疗抵抗是影响肿瘤患者放疗疗效及预后的一大难题。由于肿瘤细胞放疗抵抗的机制十分复杂,所以至今还未找到特别有效的调控放疗敏感性的开关分子。环状RNA(circRNA)是一类通过反式剪接使得 3' 末端与 5' 末端共价结合的闭合circRNA分子,具有丰度高、结构稳定和特异性强等特征。circRNA参与肿瘤的发生、发展、侵袭和转移等过程,可以作为新型肿瘤分子标志物和潜在的治疗靶点。此外,circRNA在受照后的肿瘤细胞中存在差异性表达,并可作为微小RNA(miRNA)的海绵,调控与肿瘤放疗抵抗相关的miRNA及其下游信号通路,使其有望成为攻克肿瘤放疗抵抗的突破口。笔者综述了circRNA作为新型肿瘤标志物及其在肿瘤放疗中应用的研究进展。Abstract: Radiotherapy is one of the important means of combined therapy for treating tumors. However, radioresistance is a serious issue that affects the curative effect and prognosis of radiotherapy for tumor patients. Given the complex mechanism of radioresistance in tumor cells, the specific switch molecules that can regulate radiosensitivity are not yet discovered. Circular RNA (circRNA) is a kind of closed circular RNA molecules that covalently bind the 3'-end and 5'-end by trans-splicing with high abundance, stable structure, and strong specificity. CircRNA is involved in tumorigenesis, development, invasion, and metastasis and can be used as a novel tumor molecular marker and potential therapeutic target. In addition, circRNA is differentially expressed in irradiated tumor cells and can serve as a sponge to regulate microRNA and its downstream signaling pathways that are related to tumor radioresistance. Therefore, the research on circRNA might be a promising breakthrough toward overcoming tumor radioresistance. In this study, we reviewed the progress in the research on circRNAs as novel tumor markers, as well as the research prospects regarding the application of radiotherapy.
-
Key words:
- Neoplasms /
- Circular RNA /
- Micro RNAs /
- Radiotherapy /
- Biomarkers, tumor
-
[1] Tang L, Wei F, Wu YF, et al. Role of metabolism in cancer cell radioresistance and radiosensitization methods[J]. J Exp Clin Cancer Res, 2018, 37(1): 87. DOI: 10.1186/s13046-018-0758-7. [2] Meng SJ, Zhou HC, Feng ZY, et al. CircRNA: functions and properties of a novel potential biomarker for cancer[J/OL]. Mol Cancer, 2017, 16(1): 94[2019-03-20]. https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-017-0663-2. DOI: 10.1186/s12943-017-0663-2. [3] Bolha L, Ravnik-Glavač M, Glavač D. Circular RNAs: Biogenesis, Function, and a Role as Possible Cancer Biomarkers[J]. Int J Genomics, 2017, 2017: 6218353. DOI: 10.1155/2017/6218353. [4] Xie HJ, Ren XL, Xin SN, et al. Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer[J/OL]. Oncotarget, 2016, 7(18): 26680-26691[2019-03-20]. https://www.oncotarget.com/article/8589/text/. DOI: 10.18632/oncotarget.8589. [5] Cao S, Chen GH, Yan LM, et al. Contribution of dysregulated circRNA_100876 to proliferation and metastasis of esophageal squamous cell carcinoma[J/OL]. Onco Targets Ther, 2018, 11:7385−7394[2019-03-20]. https://www.dovepress.com/contribution-of−dysregulated−circrna100876−to−proliferation−and−metast−peer−reviewed−article-OTT. DOI: 10.2147/OTT.S177524. [6] Xia WJ, Qiu MT, Chen R, et al. Circular RNA has_circ_0067934 is upregulated in esophageal squamous cell carcinoma and promoted proliferation[J/OL]. Sci Rep, 2016, 6: 35576[2019-03-20]. https://www.nature.com/articles/srep35576. DOI: 10.1038/srep35576. [7] Wang W, Ma J, Lu JJ, et al. Circ0043898 acts as a tumor inhibitor and performs regulatory effect on the inhibition of esophageal carcinoma[J]. Cancer Biol Ther, 2018, 19(12): 1117−1127. DOI: 10.1080/15384047.2018.1480889. [8] Rong J, Wang Q, Zhang YZ, et al. Circ-DLG 1 promotes the proliferation of esophageal squamous cell carcinoma[J/OL]. Onco Targets Ther, 2018, 11: 6723−6730[2019-03-20]. https://www.dovepress.com/circ−dlg−1−promotes−the−proliferation−of−esophageal−squamous−cell−carc−peer−reviewed−article-OTT. DOI: 10.2147/OTT.S175826. [9] Qi XL, Zhang DH, Wu N, et al. ceRNA in cancer: possible functions and clinical implications[J]. J Med Genet, 2015, 52(10): 710−718. DOI: 10.1136/jmedgenet-2015-103334. [10] Sun HD, Tang WW, Rong DW, et al. Hsa_circ_0000520, a potential new circular RNA biomarker, is involved in gastric carcinoma[J]. Cancer Biomark, 2018, 21(2): 299−306. DOI: 10.3233/CBM-170379. [11] Wang L, Shen JY, Jiang YS. Circ_0027599/PHDLA1 suppresses gastric cancer progression by sponging miR-101-3p.1[J/OL]. Cell Biosci, 2018, 8: 58[2019-03-20]. https://link.springer.com/article/10.1186/s13578-018-0252-0. DOI: 10.1186/s13578-018-0252-0. [12] Xie Y, Shao YF, Sun WL, et al. Downregulated expression of hsa_circ_0074362 in gastric cancer and its potential diagnostic values[J]. Biomark Med, 2018, 12(1): 11−20. DOI: 10.2217/bmm-2017−0114. [13] Tian MQ, Chen RY, Li TW, et al. Reduced expression of circRNA hsa_circ_0003159 in gastric cancer and its clinical significance[J]. J Clin Lab Anal, 2018, 32(3): e22281. DOI: 10.1002/jcla.22281. [14] Shao YF, Chen LB, Lu RD, et al. Decreased expression of hsa_circ_0001895 in human gastric cancer and its clinical significances[J]. Tumour Biol, 2017, 39(4): 1010428317699125. DOI: 10.1177/1010428317699125. [15] Gu XH, Wang G, Shen H, et al. Hsa_circ_0033155: A potential novel biomarker for non-small cell lung cancer[J]. Exp Ther Med, 2018, 16(4): 3220−3226. DOI: 10.3892/etm.2018.6565. [16] Zong L, Sun QC, Zhang HP, et al. Increased expression of circRNA_102231 in lung cancer and its clinical significance[J]. Biomed Pharmacother, 2018, 102: 639−644. DOI: 10.1016/j.biopha.2018.03.084. [17] Tian XF, Zhang L, Jiao Y, et al. CircABCB10 promotes nonsmall cell lung cancer cell proliferation and migration by regulating the miR-1252/FOXR2 axis[J]. J Cell Biochem, 2019, 120(3): 3765−3772. DOI: 10.1002/jcb.27657. [18] Chen Y, Wei SZ, Wang XY, et al. Progress in research on the role of circular RNAs in lung cancer[J/OL]. World J Surg Oncol, 2018, 16(1): 215[2019-03-20]. https://link.springer.com/article/10.1186/s12957−018−1515−2. DOI: 10.1186/s12957-018-1515-2. [19] Zhang XW, Qiu SL, Luo P, et al. Down-regulation of hsa_circ_0001649 in hepatocellular carcinoma predicts a poor prognosis[J]. Cancer Biomark, 2018, 22(1): 135−142. DOI: 10.3233/CBM-171109. [20] Zhu Q, Lu GY, Luo ZH, et al. CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324/FZD5/Wnt/β-catenin axis[J]. Biochem Biophys Res Commun, 2018, 497(2): 626−632. DOI: 10.1016/j.bbrc.2018.02.119. [21] Weng QY, Chen MJ, Li MQ, et al. Global microarray profiling identified hsa_circ_0064428 as a potential immune-associated prognosis biomarker for hepatocellular carcinoma[J]. J Med Genet, 2019, 56(1): 32−38. DOI: 10.1136/jmedgenet-2018-105440. [22] Fu LY, Jiang ZL, Li TW, et al. Circular RNAs in hepatocellular carcinoma: Functions and implications[J/OL]. Cancer Med, 2018, 7(7): 3101-3109[2019-03-20]. https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.1574. DOI: 10.1002/cam4.1574. [23] Ma HB, Yao YN, Yu JJ, et al. Extensive profiling of circular RNAs and the potential regulatory role of circRNA-000284 in cell proliferation and invasion of cervical cancer via sponging miR-506[J/OL]. Am J Transl Res, 2018, 10(2): 592-604[2019-03-20]. https://pubmed.ncbi.nlm.nih.gov/29511454/. [24] Hu CJ, Wang Y, Li A, et al. Overexpressed circ_0067934 acts as an oncogene to facilitate cervical cancer progression via the miR-545/EIF3C axis[J]. J Cell Physiol, 2019, 234(6): 9225−9232. DOI: 10.1002/jcp.27601. [25] Song TL, Xu AL, Zhang ZF, et al. CircRNA hsa_circRNA_101996 increases cervical cancer proliferation and invasion through activating TPX2 expression by restraining miR-8075[J]. J Cell Physiol, 2019, 234(8): 14296−14305. DOI: 10.1002/jcp.28128. [26] Chang HP, Wang JZ, Tian Y, et al. The TPX2 gene is a promising diagnostic and therapeutic target for cervical cancer[J]. Oncol Rep, 2012, 27(5): 1353−1359. DOI: 10.3892/or.2012.1668. [27] Jiang PY, Shen KX, Wang XR, et al. TPX2 regulates tumor growth in human cervical carcinoma cells[J]. Mol Med Rep, 2014, 9(6): 2347−2351. DOI: 10.3892/mmr.2014.2106. [28] Zhang JH, Zhao XY, Zhang J, et al. Circular RNA hsa_circ_0023404 exerts an oncogenic role in cervical cancer through regulating miR-136/TFCP2/YAP pathway[J]. Biochem Biophys Res Commun, 2018, 501(2): 428−433. DOI: 10.1016/j.bbrc.2018.05.006. [29] Liu JM, Wang DB, Long ZQ, et al. CircRNA8924 Promotes Cervical Cancer Cell Proliferation, Migration and Invasion by Competitively Binding to MiR-518d-5p/519-5p Family and Modulating the Expression of CBX8[J]. Cell Physiol Biochem, 2018, 48(1): 173−184. DOI: 10.1159/000491716. [30] Jeggo PA, Geuting V, Löbrich M. The role of homologous recombination in radiation-induced double-strand break repair[J]. Radiother Oncol, 2011, 101(1): 7−12. DOI: 10.1016/j.radonc.2011.06.019. [31] Yu D, Li YF, Ming ZH, et al. Comprehensive circular RNA expression profile in radiation-treated HeLa cells and analysis of radioresistance-related circRNAs[J/OL]. Peer J, 2018, 6: e5011[2019-03-20]. https://peerj.com/articles/5011/. DOI: 10.7717/peerj.5011. [32] Su HF, Lin FQ, Deng X, et al. Profiling and bioinformatics analyses reveal differential circular RNA expression in radioresistant esophageal cancer cells[J/OL]. J Transl Med, 2016, 14(1): 225[2019-03-20]. https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-016-0977-7. DOI: 10.1186/s12967-016-0977-7. [33] O'Leary VB, Smida J, Matjanovski M, et al. The CircRNA interactome-innovative hallmarks of the intra- and extracellular radiation response[J/OL]. Oncotarget, 2017, 8(45): 78397−78409[2019-03-20]. https://www.oncotarget.com/article/19228/text/. DOI: 10.18632/oncotarget.19228. [34] Shuai MX, Hong JW, Huang DH, et al. Upregulation of circRNA_0000285 serves as a prognostic biomarker for nasopharyngeal carcinoma and is involved in radiosensitivity[J]. Oncol Lett, 2018, 16(5): 6495−6501. DOI: 10.3892/ol.2018.9471. [35] Toulany M, Rodemann HP. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation[J]. Semin Cancer Biol, 2015, 35: 180−190. DOI: 10.1016/j.semcancer.2015.07.003. [36] Kim Y, Kim KH, Lee J, et al. Wnt activation is implicated in glioblastoma radioresistance[J]. Lab Invest, 2012, 92(3): 466−473. DOI: 10.1038/labinvest.2011.161. [37] Cojoc M, Peitzsch C, Kurth A, et al. Aldehyde Dehydrogenase Is Regulated by Β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells[J]. Cancer Res, 2015, 75(7): 1482−1494. DOI: 10.1158/0008-5472.CAN-14-1924. [38] Bar-Ad V, Leiby B, Witek M, et al. Treatment-related Acute Esophagitis For Patients With Locoregionally Advanced Non-Small Cell Lung Cancer Treated With Involved-field Radiotherapy and Concurrent Chemotherapy[J]. Am J Clin Oncol, 2014, 37(5): 433−437. DOI: 10.1097/COC.0b013e31827de7a2. [39] Luo JD, Zhang CS, Zhan Q, et al. Profiling circRNA and miRNA of radiation-induced esophageal injury in a rat model[J/OL]. Sci Rep, 2018, 8(1): 14605[2019-03-20]. https://www.nature.com/articles/s41598-018-33038-1. DOI: 10.1038/s41598-018-33038-1. [40] Lu QY, Gong W, Wang JH, et al. Identification of Circular RNAs Altered in Mouse Jejuna After Radiation[J]. Cell Physiol Biochem, 2018, 47(6): 2558−2568. DOI: 10.1159/000491652. [41] Yu L, Gong Xj, Sun L, et al. The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression[J/OL]. PLoS One, 2016, 11(7): e0158347[2019-03-20]. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0158347. DOI: 10.1371/journal.pone.0158347.
计量
- 文章访问数: 5633
- HTML全文浏览量: 4962
- PDF下载量: 21